Company Filing History:
Years Active: 2021
Title: Innovations of Chung-Hsiung Huang in Nanoemulsion Adjuvants
Introduction
Chung-Hsiung Huang is a notable inventor based in Zhunan Town, Taiwan. He has made significant contributions to the field of immunology through his innovative work on nanoemulsion adjuvants. His research focuses on enhancing vaccine efficacy while minimizing potential toxicity.
Latest Patents
Chung-Hsiung Huang holds a patent for a "Nanoemulsion adjuvant for nasal mucosa and preparation method thereof." This invention provides a nanoemulsion adjuvant composed of a continuous aqueous phase containing HO molecules, an oil phase material with fats and oils, and an emulsion system that stabilizes the interface between the two phases. Notably, the emulsion system does not contain ionic emulsifiers, and the particle size of the emulsion ranges between 20 and 200 nanometers. This innovative approach helps prevent toxicity and potential harm to human cells, while also providing a vaccine preparation that can elicit a high degree of immune response. He has 1 patent to his name.
Career Highlights
Chung-Hsiung Huang is affiliated with the National Health Research Institutes, where he conducts his research and development activities. His work is pivotal in advancing vaccine technology and improving public health outcomes.
Collaborations
Chung-Hsiung Huang collaborates with esteemed colleagues, including Ming-Hsiung Huang and Chiung-Yi Huang, to further enhance the impact of his research in the field of immunology.
Conclusion
Chung-Hsiung Huang's innovative contributions to the development of nanoemulsion adjuvants represent a significant advancement in vaccine technology. His work not only addresses safety concerns but also aims to improve immune responses, showcasing the importance of innovation in public health.